Merck KGaA

Merck KGaA

MerckMerck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

www.merckgroup.com

Filters
List of articles in category Merck KGaA
Title Published Date
FY2009: Merck KGaA Revenues Rise by 2.1% to € 7.7 Billion 24 February 2010
New Data From CLARITY Study on Disease Activity in MS Patients 12 September 2009
Merck KGaA Submits Application for Cladribine Tablets as Multiple Sclerosis Therapy in Europe 24 July 2009
Q1/2009: Merck Revenues Remain Stable at € 1.9 Billion 28 April 2009
Annual General Meeting of Merck KGaA: Shareholders Approve Dividend of € 1.50 per Share 04 April 2009
Merck KGaA Launches Strategic Venture Capital Fund 23 March 2009
Merck KGaA and Fast Forward, LLC Announce Collaboration 18 March 2009
The safety of patients is of utmost importance to Merck 21 February 2009
Merck: 2008 Operating Result Rises 16% to € 1,131 Million 18 February 2009
Oral Investigational Multiple Sclerosis Treatment to Complete a Two-Year Pivotal Study 23 January 2009
Merck KGaA and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics 13 January 2009
Merck KGaA's Kuvan Receives Marketing Authorization in Europe 08 December 2008
Merck KGaA Acquires Bio-Fyt Pharma in Belgium 01 December 2008